Nasopharyngeal carcinoma signaling pathway: An update on molecular biomarkers

International Journal of Cell Biology

Volumn , Issue , 2012, Pages

  Tulalamba, Warut ^a   Janvilisri, Tavan ^a  

^a Mahidol University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; BIOLOGICAL MARKER; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MOLECULAR MARKER; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P16; PROTEIN P21; PROTEIN P53; PROTEIN P63; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR AP 1; UNINDEXED DRUG; UVOMORULIN; WNT PROTEIN;

ADVANCED CANCER; APOPTOSIS; CANCER GROWTH; CANCER STAGING; CELL ADHESION; CELL PROLIFERATION; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; HEREDITY; HUMAN; MOLECULAR PATHOLOGY; NASOPHARYNX CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

HUMAN HERPESVIRUS 4;

EID: 84859783500     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2012/594681     Document Type: Review

References (130)

1. Sham J. S. T., Wei W. I., Yong-Sheng Z., Choy D., Yan-Qin G., Yan L., Zhi-Xiong L., Ng M. H., Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy Lancet 1990 335 8686 371 374 (Pubitemid 20059350)
2. Chang E. T., Adami H. O., The enigmatic epidemiology of nasopharyngeal carcinoma Cancer Epidemiology Biomarkers and Prevention 2006 15 10 1765 1777 (Pubitemid 44664247)
3. Parkin D. M., Muir C. S., Cancer incidence in five continents. Comparability and quality of data IARC Scientific Publications 1992 120 45 173
4. Nielsen N. H., Mikkelsen F., Hansen J. P. H., Nasopharyngeal cancer in Greenland. The incidence in an Arctic Eskimo population Acta Pathologica et Microbiologica Scandinavica 1977 85 6 850 858 (Pubitemid 8245849)
5. Brennan B., Nasopharyngeal carcinoma Orphanet Journal of Rare Diseases 2006 1 1, article 23
6. Li Y. H., Hu C. F., Shao Q., Huang M. Y., Hou J. H., Xie D., Zeng Y. X., Shao J. Y., Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma Journal of Translational Medicine 2008 6, article 1
7. Marcus K. J., Tishler R. B., Head and neck carcinomas across the age spectrum: epidemiology, therapy, and late effects Seminars in Radiation Oncology 2010 20 1 52 57
8. Greene F. L., Page D. L., Fleming I. D., AJCC Cancer Staging Manual 2002 New York, NY, USA Springer
9. Chang J. T. C., Ko J. Y., Hong R. L., Recent advances in the treatment of nasopharyngeal carcinoma Journal of the Formosan Medical Association 2004 103 7 496 510
10. Wang H. Y., Zhang M., He P. C., Yang B. J., Shao L. Y., Shao W. B., Changes of gene expression profile in human myeloma cell line induced by thalidomide Journal of Experimental Hematology 2010 18 2 396 402
11. Logan C. Y., Nusse R., The Wnt signaling pathway in development and disease Annual Review of Cell and Developmental Biology 2004 20 781 810 (Pubitemid 39488658)
12. Bhanot P., Brink M., Samos C. H., Hsieh J. C., Wang Y., Macke J. P., Andrew D., Nathans J., Nusse R., A new member of the frizzled family from Drosophila functions as a wingless receptor Nature 1996 382 6588 225 231 (Pubitemid 26251350)
13. Yang-Snyder J., Miller J. R., Brown J. D., Lai C. J., Moon R. T., A frizzled homolog functions in a vertebrate Wnt signaling pathway Current Biology 1996 6 10 1302 1306 (Pubitemid 27004915)
14. Noordermeer J., Klingensmith J., Perrimon N., Nusse R., Dishevelled and armadillo act in the wingless signalling pathway in Drosophila Nature 1994 367 6458 80 83
15. Nelson W. J., Nusse R., Convergence of Wnt, -catenin, and cadherin pathways Science 2004 303 5663 1483 1487 (Pubitemid 38314410)
16. Polakis P., Wnt signaling and cancer Genes and Development 2000 14 15 1837 1851 (Pubitemid 30639518)
17. Jou T. S., Stewart D. B., Stappert J., Nelson W. J., Marrs J. A., Genetic and biochemical dissection of protein linkages in the cadherin- catenin complex Proceedings of the National Academy of Sciences of the United States of America 1995 92 11 5067 5071
18. Zhang Q., Yu L., Liu L., Wang S., Yang Y., Ding Y., Divakaran J., Li X., Ding Y., LMP1 antagonizes WNT/ -catenin signalling through inhibition of WTX and promotes nasopharyngeal dysplasia but not tumourigenesis in LMP1 B95-8 transgenic mice Journal of Pathology 2011 223 5 574 583
19. Mazieres J., He B., You L., Xu Z., Jablons D. M., Wnt signaling in lung cancer Cancer Letters 2005 222 1 1 10 (Pubitemid 40544841)
20. Hollande F., Pannequin J., Joubert D., The long road to colorectal cancer therapy: searching for the right signals Drug Resistance Updates 2010 13 1-2 44 56
21. Gandhirajan R. K., Poll-Wolbeck S. J., Gehrke I., Kreuzer K. A., Wnt/ -catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options Current Cancer Drug Targets 2010 10 7 716 727
22. Clément G., Jablons D. M., Benhattar J., Targeting the Wnt signaling pathway to treat Barrett's esophagus Expert Opinion on Therapeutic Targets 2007 11 3 375 389 (Pubitemid 46290960)
23. Lo A. K. F., Liu Y., Wang X. H., Huang D. P., Yuen P. W., Wong Y. C., Tsao G. S. W., Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1 Laboratory Investigation 2003 83 5 697 709 (Pubitemid 36618048)
24. Sriuranpong V., Mutirangura A., Gillespie J. W., Patel V., Amornphimoltham P., Molinolo A. A., Kerekhanjanarong V., Supanakorn S., Supiyaphun P., Rangdaeng S., Voravud N., Gutkind J. S., Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays Clinical Cancer Research 2004 10 15 4944 4958 (Pubitemid 39099768)
25. Shi W., Bastianutto C., Li A., Perez-Ordonez B., Ng R., Chow K. Y., Zhang W., Jurisica I., Lo K. W., Bayley A., Kim J., O'Sullivan B., Siu L., Chen E., Liu F. F., Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling International Journal of Cancer 2006 119 10 2467 2475 (Pubitemid 44546973)
26. Zeng Z. Y., Zhou Y. H., Zhang W. L., Xiong W., Fan S. Q., Li X. L., Luo X. M., Wu M. H., Yang Y. X., Huang C., Cao L., Tang K., Qian J., Shen S. R., Li G. Y., Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway Human Pathology 2007 38 1 120 133 (Pubitemid 44880208)
27. Chou J., Lin Y. C., Kim J., You L., Xu Z., He B., Jablons D. M., Nasopharyngeal carcinomareview of the molecular mechanisms of tumorigenesis Head and Neck 2008 30 7 946 963 (Pubitemid 352008957)
28. Lin Y. C., You L., Xu Z., He B., Mikami I., Thung E., Chou J., Kuchenbecker K., Kim J., Raz D., Yang C. T., Chen J. K., Jablons D. M., Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines Biochemical and Biophysical Research Communications 2006 341 2 635 640 (Pubitemid 43152150)
29. Fendri A., Khabir A., Hadri-Guiga B., Sellami-Boudawara T., Daoud J., Frikha M., Ghorbel A., Gargouri A., Mokdad-Gargouri R., Epigenetic alteration of the Wnt inhibitory factor-1 promoter is common and occurs in advanced stage of Tunisian nasopharyngeal carcinoma Cancer Investigation 2010 28 9 896 903
30. Morrison J. A., Gulley M. L., Pathmanathan R., Raab-Traub N., Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma Cancer Research 2004 64 15 5251 5260 (Pubitemid 39006545)
31. Everly D. N. Jr. , Kusano S., Raab-Traub N., Accumulation of cytoplasmic -catenin and nuclear glycogen synthase kinase 3 in epstein-barr virus-infected cells Journal of Virology 2004 78 21 11648 11655 (Pubitemid 39390751)
32. Morrison J. A., Raab-Traub N., Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of -catenin signaling Journal of Virology 2005 79 4 2375 2382 (Pubitemid 40204592)
33. Wang F.-L., Guo X., Yuan T.-Z., Cao S.-M., Rao H.-L., Hou J.-H., Shao Q., Li N.-W., Hong M.-H., Expression and clinical significance of Wnt-1 and -catenin in nasopharyngeal carcinoma Chinese Journal of Cancer 2009 28 1 72 75
34. Zhang W., Zeng Z., Zhou Y., Xiong W., Fan S., Xiao L., Huang D., Li Z., Li D., Wu M., Li X., Shen S., Wang R., Cao L., Tang K., Li G., Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis Acta Biochimica et Biophysica Sinica 2009 41 5 414 428
35. Robles A. I., Larcher F., Whalin R. B., Murillas R., Richie E., Gimenez-Conti I. B., Jorcano J. L., Conti C. J., Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 7634 7638 (Pubitemid 26277088)
36. Zhou B. B. S., Elledge S. J., The DNA damage response: putting checkpoints in perspective Nature 2000 408 6811 433 439
37. Hwang C. F., Cho C. L., Huang C. C., Wang J. S., Shih Y. L., Su C. Y., Chang H. W., Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy Annals of Oncology 2002 13 8 1246 1251
38. Michalides R., Van Veelen N., Hart A., Loftus B., Wientjens E., Balm A., Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck Cancer Research 1995 55 5 975 978
39. Ren Q., Sato H., Murono S., Furukawa M., Yoshizaki T., Epstein-Barr Virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor- B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line Laryngoscope 2004 114 5 855 859 (Pubitemid 38625536)
40. Man C., Rosa J., Lee L. T. O., Lee V. H. Y., Chow B. K. C., Lo K. W., Doxsey S., Wu Z. G., Kwong Y. L., Jin D. Y., Cheung A. L. M., Tsao S. W., Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells Oncogene 2007 26 21 3069 3080 (Pubitemid 46733640)
41. Brooks L., Yao Q. Y., Rickinson A. B., Young L. S., Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts Journal of Virology 1992 66 5 2689 2697
42. Li Z., Ren Y., Lin S. X., Liang Y. J., Liang H. Z., Association of E-cadherin and -catenin with metastasis in nasopharyngeal carcinoma Chinese Medical Journal 2004 117 8 1232 1239 (Pubitemid 39199933)
43. Galera-Ruiz H., Ros M. J., Gonzlez-Cmpora R., De Miguel M., Carmona M. I., Moreno A. M., Galera-Davidson H., The cadherin-catenin complex in nasopharyngeal carcinoma European Archives of Oto-Rhino-Laryngology 2011 268 9 1335 1341
44. Fendri A., Khabir A., Mnejja W., Sellami-Boudawara T., Daoud J., Frikha M., Ghorbel A., Gargouri A., Mokdad-Gargouri R., PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma Cancer Science 2009 100 11 2034 2039
45. Mendoza M. C., Er E. E., Blenis J., The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation Trends in Biochemical Sciences 2011 36 6 320 328
46. Song G., Ouyang G., Bao S., The activation of Akt/PKB signaling pathway and cell survival Journal of Cellular and Molecular Medicine 2005 9 1 59 71
47. Worsham M. J., Pals G., Schouten J. P., Van Spaendonk R. M. L., Concus A., Carey T. E., Benninger M. S., Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma Archives of Otolaryngology 2003 129 7 702 708 (Pubitemid 36858953)
48. Mei Y. P., Zhou J. M., Wang Y., Huang H., Deng R., Feng G. K., Zeng Y. X., Zhu X. F., Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells Cell Cycle 2007 6 11 1379 1385 (Pubitemid 47327973)
49. zyar E., Ayhan A., Korcum A. F., Atahan I. L., Prognostic role of Ebstein-Barr virus latent membrane protein-1 and Interleukin-10 expression in patients with nasopharyngeal carcinoma Cancer Investigation 2004 22 4 483 491 (Pubitemid 39506867)
50. Li H. M., Zhuang Z., Wang Q., Pang J. C. S., Wang X. H., Wong H. L., Feng H. C., Jin D. Y., Ling M. T., Wong Y. C., Eliopoulos A. G., Young L. S., Huang D. P., Tsao S. W., Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells Oncogene 2004 23 25 4488 4494 (Pubitemid 38850427)
51. Tsao S. W., Tramoutanis G., Dawson C. W., Lo A. K. F., Huang D. P., The significance of LMP1 expression in nasopharyngeal carcinoma Seminars in Cancer Biology 2002 12 6 473 487 (Pubitemid 35370760)
52. Mainou B. A., Everly D. N. Jr. , Raab-Traub N., Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K Oncogene 2005 24 46 6917 6924 (Pubitemid 41509414)
53. Milde-Langosch K., The Fos family of transcription factors and their role in tumourigenesis European Journal of Cancer 2005 41 16 2449 2461 (Pubitemid 41540622)
54. Wang X. P., Sun L. G., Liu N., Yu H. Y., Zhang Y., Shan Y. Q., Effects of basic fibroblast growth factor on protein kinase B activity and c-fos expression in CNE- I nasopharyngeal carcinoma cell line Zhonghua Er Bi Yan Hou Ke Za Zhi 2004 39 679 682
55. Jiang H., Fan D., Zhou G., Li X., Deng H., Zhen L., Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo Journal of Experimental amp; Clinical Cancer Research 2010 29, article 34
56. Garcia Pedrero J. M., Garcia Carracedo D., Muoz Pinto C., Herrero Zapatero A., Rodrigo J. P., Suarez Nieto C., Gonzalez M. V., Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma International Journal of Cancer 2005 114 2 242 248 (Pubitemid 40194293)
57. Xu X., Yang H., Huo X., Expression and significance of PTEN in nasopharyngeal carcinoma Journal of Clinical Otorhinolaryngology 2004 18 11 658 659
58. Schagdarsurengin U., Gimm O., Dralle H., Hoang-Vu C., Dammann R., CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma Thyroid 2006 16 7 633 642
59. Kwong J., Lo K. W., To K. F., Teo P. M. L., Johnson P. J., Poon Huang D., Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma Clinical Cancer Research 2002 8 1 131 137 (Pubitemid 34101468)
60. West K. A., Brognard J., Clark A. S., Linnoila I. R., Yang X., Swain S. M., Harris C., Belinsky S., Dennis P. A., Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells Journal of Clinical Investigation 2003 111 1 81 90 (Pubitemid 36134851)
61. Cowan K. J., Storey K. B., Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress Journal of Experimental Biology 2003 206 7 1107 1115 (Pubitemid 36409152)
62. Seger R., Krebs E. G., The MAPK signaling cascade FASEB Journal 1995 9 9 726 735
63. Hammaker D., Firestein G. S., Go upstream, young man: lessons learned from the p38 saga Annals of the Rheumatic Diseases 2010 69 1 i77 i82
64. Chen Y. R., Wang X., Templeton D., Davis R. J., Tan T. H., The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and radiation. Duration of JNK activation may determine cell death and proliferation Journal of Biological Chemistry 1996 271 50 31929 31936 (Pubitemid 26422216)
65. Tang F., Tang G., Xiang J., Dai Q., Rosner M. R., Lin A., The absence of NF- B-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis Molecular and Cellular Biology 2002 22 24 8571 8579 (Pubitemid 35397172)
66. Potapova O., Anisimov S. V., Gorospe M., Dougherty R. H., Gaarde W. A., Boheler K. R., Holbrook N. J., Targets of c-Jun NH2-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression Cancer Research 2002 62 11 3257 3263 (Pubitemid 34602422)
67. Eliopoulos A. G., Young L. S., Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) Oncogene 1998 16 13 1731 1742 (Pubitemid 28175054)
68. Tsai C. L., Li H. P., Lu Y. J., Hsueh C., Liang Y., Chen C. L., Tsao S. W., Tse K. P., Yu J. S., Chang Y. S., Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH 2-terminal kinase signaling Cancer Research 2006 66 24 11668 11676 (Pubitemid 46094178)
69. Shklyaev S. S., Namba H., Sautin Y., Mitsutake N., Nagayama Y., Ishikawa N., Ito K., Zeki K., Yamashita S., Involvement of wild-type p53 in radiation-induced c-jun N-terminal kinase activation in human thyroid cells Anticancer Research 2001 21 4 A 2569 2575 (Pubitemid 33054426)
70. Chen M. K., Lee H. S., Chang J. H., Chang C. C., Expression of p53 protein and primary tumour volume in patients with nasopharyngeal carcinoma Journal of Otolaryngology 2004 33 5 304 307 (Pubitemid 40459383)
71. Li L., Guo L., Tao Y., Zhou S., Wang Z., Luo W., Hu D., Li Z., Xiao L., Tang M., Yi W., Tsao S. W., Cao Y., Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases Cancer Letters 2007 255 2 219 231 (Pubitemid 47271954)
72. Shklyaev S. S., Namba H., Mitsutake N., Alipov G., Nagayama Y., Maeda S., Ohtsuru A., Tsubouchi H., Yamashita S., Transient activation of c-Jun NH2-terminal kinase by growth factors influences survival but not apoptosis of human thyrocytes Thyroid 2001 11 7 629 636 (Pubitemid 32701583)
73. Schmidt M., Goebeler M., Posern G., Feller S. M., Seitz C. S., Brcker E. B., Rapp U. R., Ludwig S., Ras-independent activation of the Raf/MEK/ERK pathway upon calcium-induced differentiation of keratinocytes Journal of Biological Chemistry 2000 275 52 41011 41017 (Pubitemid 32054928)
74. Bancroft C. C., Chen Z., Dong G., Sunwoo J. B., Yeh N., Park C., Van Waes C., Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF- B signal pathways Clinical Cancer Research 2001 7 2 435 442 (Pubitemid 32183050)
75. Treinies I., Paterson H. F., Hooper S., Wilson R., Marshall C. J., Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis Molecular and Cellular Biology 1999 19 1 321 329 (Pubitemid 29018434)
76. Treisman R., Regulation of transcription by MAP kinase cascades Current Opinion in Cell Biology 1996 8 2 205 215 (Pubitemid 26109094)
77. Yung W. C. W., Sham J. S. T., Choy D. T. K., Ng M. H., ras Mutations are uncommon in nasopharyngeal carcinoma European Journal of Cancer Part B 1995 31 6 399 400
78. Bang Y. J., Kwon J. H., Kang S. H., Kim J. W., Yang Y. C., Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma Biochemical and Biophysical Research Communications 1998 250 1 43 47 (Pubitemid 28448619)
79. Schmidt C. M., McKillop I. H., Cahill P. A., Sitzmann J. V., Increased MAPK expression and activity in primary human hepatocellular carcinoma Biochemical and Biophysical Research Communications 1997 236 1 54 58 (Pubitemid 27341838)
80. Oka H., Chatani Y., Hoshino R., Ogawa O., Kakehi Y., Terachi T., Okada Y., Kawaichi M., Kohno M., Yoshida O., Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma Cancer Research 1995 55 18 4182 4187
81. Roberts P. J., Der C. J., Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 2007 26 22 3291 3310 (Pubitemid 46763022)
82. Downward J., Targeting RAS signalling pathways in cancer therapy Nature Reviews Cancer 2003 3 1 11 22 (Pubitemid 37328883)
83. Ruan L., Wang G. L., Yi H., Chen Y., Tang C. E., Zhang P. F., Li M. Y., Li C., Peng F., Li J. N., Chen Z. C., Xiao Z. Q., Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy Journal of Cellular Biochemistry 2010 110 4 975 984
84. Wong V. C. L., Chen H., Ko J. M. Y., Chan K. W., Chan Y. P., Law S., Chua D., Kwong D. L.-W., Lung H. L., Srivastava G., Tang J. C. O., Tsao S. W., Zabarovsky E. R., Stanbridge E. J., Lung M. L., Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype International Journal of Cancer 2012 130 1 83 95
85. Kerkhoff E., Rapp U. R., Cell cycle targets of Ras/Raf signalling Oncogene 1998 17 11 1457 1462 (Pubitemid 28458413)
86. Zhang Z., Sun D., Do N. V., Tang A., Hu L., Huang G., Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma International Journal of Cancer 2007 120 1 32 38 (Pubitemid 44901914)
87. Wang S. S., Guan Z. Z., Xiang Y. Q., Wang B., Lin T. Y., Jiang W. Q., Zhang L., Zhang H. Z., Hou J. H., Significance of EGFR and p-ERK expression in nasopharyngeal carcinoma Chinese Journal of Oncology 2006 28 1 28 31
88. Yang H. J., Cho Y. J., Kim H. S., Chang M. S., Sung M. W., Kim W. H., Association of p53 and bcl-2 expression with Epstein-Barr virus infection in the cancers of head and neck Head and Neck 2001 23 8 629 636 (Pubitemid 32643106)
89. Chen M. K., Yang S. F., Lai J. C., Yeh K. T., Yang J. S., Chen L. S., Chen H. C., Expression of bcl-2 correlates with poor prognosis and modulates migration of nasopharyngeal carcinoma cells Clinica Chimica Acta 2010 411 5-6 400 405
90. Fendri A., Kontos C. K., Khabir A., Mokdad-Gargouri R., Scorilas A., BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma Molecular Medicine 2011 17 3-4 163 171
91. Yip K. W., Shi W., Pintilie M., Martin J. D., Mocanu J. D., Wong D., MacMillan C., Gullane P., O'Sullivan B., Bastianutto C., Liu F. F., Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer Clinical Cancer Research 2006 12 19 5726 5732 (Pubitemid 44629602)
92. Yu Y., Dong W., Li X., Yu E., Zhou X., Li S., Significance of c-Myc and Bcl-2 protein expression in nasopharyngeal carcinoma Archives of Otolaryngology 2003 129 12 1322 1326 (Pubitemid 37523107)
93. Sheu L. F., Chen A., Lee H. S., Hsu H. Y., Yu D. S., Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells Pathology International 2004 54 7 475 485 (Pubitemid 38951663)
94. Chen M. K., Lai J. C., Chang C. C., Chang J. H., Chang Y. J., Chen H. C., Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma Head and Neck 2008 30 8 1052 1057
95. Li J. X., Zhou K. Y., Cai K. R., Liang T., Tang X. D., Zhang Y. F., Knockdown of bcl-xL expression with RNA interference induces nasopharyngeal carcinoma cells apoptosis Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2005 40 5 347 351
96. Burgos J. S., Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis Medical Oncology 2005 22 2 113 121 (Pubitemid 41003443)
97. Wu H. C., Lu T. Y., Lee J. J., Hwang J. K., Lin Y. J., Wang C. K., Lin C. T., MDM2 expression in EBV-infected nasopharyngeal carcinoma cells Laboratory Investigation 2004 84 12 1547 1556
98. Lo A. K. F., Kwok W. L., Sai W. T., Hing L. W., Hui J. W. Y., Ka F. T., Hayward S. D., Yiu L. C., Yu L. L., Takada K., Huang D. P., Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells Neoplasia 2006 8 3 173 180 (Pubitemid 43671232)
99. Deng L., Yang J., Zhao X. R., Deng X. Y., Zeng L., Gu H. H., Tang M., Cao Y., Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1 Cell Research 2003 13 3 187 194
100. Yoshizaki T., Ito M., Murono S., Wakisaka N., Kondo S., Endo K., Current understanding and management of nasopharyngeal carcinoma Auris Nasus Larynx 2012 39 2 137 144
101. Zhang Y., Xiong Y., Yarbrough W. G., ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways Cell 1998 92 6 725 734 (Pubitemid 28155312)
102. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M. D., Dtsch V., Andrews N. C., Caput D., McKeon F., p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Molecular Cell 1998 2 3 305 316 (Pubitemid 128379271)
103. Crook T., Nicholls J. M., Brooks L., O'Nions J., Allday M. J., High level expression of N-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 2000 19 30 3439 3444 (Pubitemid 30479339)
104. Potapova O., Gorospe M., Dougherty R. H., Dean N. M., Gaarde W. A., Holbrook N. J., Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner Molecular and Cellular Biology 2000 20 5 1713 1722 (Pubitemid 30100190)
105. Fu S.-M., Wang Y.-T., Tu Z.-H., Deng L.-Q., Liang Z., Lin Z.-Q., Cai J.-H., Gong X.-J., Study on the expression of survivin mRNA and protein in nasopharyngeal carcinoma Chinese Journal of Medical Genetics 2008 25 2 179 182 (Pubitemid 351548545)
106. Faqing T., Zhi H., Liqun Y., Min T., Huanhua G., Xiyun D., Ya C., Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of survivin in nasopharyngeal carcinoma Experimental Oncology 2005 27 2 96 101 (Pubitemid 41025729)
107. Ai M. D., Zhao X. R., Wu Y., Gong J. P., Cao Y., Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines Cell Research 2005 15 10 777 784 (Pubitemid 41653915)
108. Xiang Y., Yao H., Wang S., Hong M., He J., Cao S., Min H., Song E., Guo X., Prognostic value of Survivin and Livin in nasopharyngeal carcinoma Laryngoscope 2006 116 1 126 130 (Pubitemid 44383976)
109. Jiang W., Liao Y., Zhao S., Role of enhanced radiosensitivity and the tumor-specific suicide gene vector in gene therapy of nasopharyngeal carcinoma Journal of Radiation Research 2007 48 211 218 (Pubitemid 46884355)
110. Liu J. P., Cassar L., Pinto A., Li H., Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma Cell Research 2006 16 10 809 817 (Pubitemid 44599794)
111. Li H. M., Man C., Jin Y., Deng W., Yip Y. L., Feng H. C., Cheung Y. C., Lo K. W., Meltzer P. S., Wu Z. G., Kwong Y. L., Yuen A. P. W., Tsao S. W., Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase International Journal of Cancer 2006 119 7 1567 1576 (Pubitemid 44258762)
112. Ding L., Yang J., Yong G. T., Ye M., Shi Y., Tang M., Yi W., Xiao L. L., Jian P. G., Cao Y., Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor- B p65 in human nasopharyngeal carcinoma cells International Journal of Biochemistry and Cell Biology 2005 37 9 1881 1889 (Pubitemid 40961672)
113. Yang J., Deng X., Deng L., Gu H., Fan W., Cao Y., Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells Journal of Experimental and Clinical Cancer Research 2004 23 3 495 506 (Pubitemid 39490636)
114. Chua D. T. T., Nicholls J. M., Sham J. S. T., Au G. K. H., Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy International Journal of Radiation Oncology Biology Physics 2004 59 1 11 20 (Pubitemid 38501502)
115. Pan J., Kong L., Lin S., Chen G., Chen Q., Lu J. J., The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma Laryngoscope 2008 118 11 1970 1975
116. Sheen T. S., Huang Y. T., Chang Y. L., Ko J. Y., Wu C. S., Yu Y. C., Tsai C. H., Hsu M. M., Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma Japanese Journal of Cancer Research 1999 90 12 1285 1292
117. Soo R., Putti T., Tao Q., Goh B. C., Lee K. H., Kwok-Seng L., Tan L., Hsieh W. S., Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression Archives of Otolaryngology 2005 131 2 147 152 (Pubitemid 40204772)
118. Zheng X., Hu L., Chen F., Christensson B., Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma European Journal of Cancer Part B 1994 30 5 290 295 (Pubitemid 24309207)
119. Goustin A. S., Leof E. B., Shipley G. D., Moses H. L., Growth factors and cancer Cancer Research 1986 46 3 1015 1029 (Pubitemid 16048224)
120. Tao Y., Song X., Deng X., Xie D., Lee L. M., Liu Y., Li L., Deng L., Wu Q., Gong J., Cao Y., Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1 Experimental Cell Research 2005 303 2 240 251 (Pubitemid 40126259)
121. Hsu C. H., Gao M., Chen C. L., Yeh P. Y., Cheng A. L., Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro Oncology 2005 68 4-6 538 547 (Pubitemid 41160987)
122. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 2 281 297
123. Stefani G., Slack F. J., Small non-coding RNAs in animal development Nature Reviews Molecular Cell Biology 2008 9 3 219 230 (Pubitemid 351301826)
124. Bartel D. P., MicroRNAs: target recognition and regulatory functions Cell 2009 136 2 215 233
125. Cosmopoulos K., Pegtel M., Hawkins J., Moffett H., Novina C., Middeldorp J., Thorley-Lawson D. A., Comprehensive profiling of epstein-barr virus microRNAs in nasopharyngeal carcinoma Journal of Virology 2009 83 5 2357 2367
126. Wong A. M. G., Kong K. L., Tsang J. W. H., Kwong D. L. W., Guan X.-Y., Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs Cancer 2012 118 3 698 710
127. Lo A. K. F., Ka F. T., Kwok W. L., Lung R. W. M., Hui J. W. Y., Liao G., Hayward S. D., Modulation of LMP1 protein expression by EBV-encoded microRNAs Proceedings of the National Academy of Sciences of the United States of America 2007 104 41 16164 16169 (Pubitemid 350099379)
128. Kaykas A., Sugden B., The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation Oncogene 2000 19 11 1400 1410 (Pubitemid 30171171)
129. Chen H. C., Chen G. H., Chen Y. H., Liao W. L., Liu C. Y., Chang K. P., Chang Y. S., Chen S. J., MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma British Journal of Cancer 2009 100 6 1002 1011
130. Sengupta S., Den Boon J. A., Chen I. H., Newton M. A., Stanhope S. A., Cheng Y. J., Chen C. J., Hildesheim A., Sugden B., Ahlquist P., MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins Proceedings of the National Academy of Sciences of the United States of America 2008 105 15 5874 5878 (Pubitemid 351758465)